Drawing for STAGO

USPTO serial 88235051

STAGO

Reviewed by CopyMark Law Group

Reg. 5805360Status 702Registered
Filing date
Status date
Registration date
Jul 16, 2019
Examiner
SCHMIDT, JOHN JOSEPH
Law office
Historical data usage

What this means

Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use. Continue use in commerce and plan for the 10-year Section 8 and 9 renewal.

Status 702: Status 702 means the registration is active, Section 8 was accepted, and a Section 15 declaration of incontestability was also accepted. Incontestability strengthens your rights by limiting certain challenges after five years of continuous use.

Need help with STAGO?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

Todd A. VAUGHN

Todd A. VAUGHN Jordan IP Law, LLC1701 Pennsylvania Ave, NW, Suite 200Washington, DC 20006United States

Goods and services

ClassDescriptionStatusFirst use
005Chemical diagnostic reagents for medical use, for use in analysis of bodily fluids, for testing chemical biologic reactivity, for quantity determinations and for use as diagnostic controls in medical laboratories, all for use in human and veterinary medicineACTIVEDec 16, 2008
010Measuring instruments for use in medical analysis in hospitals and private medical laboratories, namely, hemostasis analysersACTIVEDec 16, 2008

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 1, 2025NA85NOTICE OF ACCEPTANCE OF SEC. 8 & 15 - E-MAILED—
Oct 1, 2025C15AREGISTERED - SEC. 8 (6-YR) ACCEPTED & SEC. 15 ACK.—
Oct 1, 2025APRECASE ASSIGNED TO POST REGISTRATION PARALEGAL—
May 23, 2025E815TEAS SECTION 8 & 15 RECEIVED—
Dec 3, 2024EWAFTEAS WITHDRAWAL OF ATTORNEY RECEIVED-FIRM RETAINS—
Dec 3, 2024TCCATEAS CHANGE OF CORRESPONDENCE RECEIVED—
Dec 3, 2024ECDRTEAS CHANGE OF DOMESTIC REPRESENTATIVES ADDRESS—
Dec 3, 2024ARAAATTORNEY/DOM.REP.REVOKED AND/OR APPOINTEDThis event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action.
Dec 3, 2024REAPTEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED—
Dec 3, 2024CHANAPPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED—
Dec 3, 2024COARTEAS CHANGE OF OWNER ADDRESS RECEIVED—
Jul 16, 2024REM1COURTESY REMINDER - SEC. 8 (6-YR) E-MAILED—
Jul 16, 2019R.PRREGISTERED-PRINCIPAL REGISTERYour trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive.
Apr 30, 2019NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Apr 30, 2019PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Apr 10, 2019NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Mar 19, 2019CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Mar 15, 2019DOCKASSIGNED TO EXAMINER—
Jan 11, 2019MDSCNOTICE OF DESIGN SEARCH CODE E-MAILED—
Jan 10, 2019NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Dec 22, 2018NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance